Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With a Blood Test That Meets the Centers for Medicare & Medicaid Services Coverage DecisionRosita van den Puttelaar, Iris Lansdorp‐Vogelaar, Pedro Nascimento de Lima et al.|Gastroenterology|2024Cited by 62
Impact and Recovery from COVID-19–Related Disruptions in Colorectal Cancer Screening and Care in the US: A Scenario AnalysisRosita van den Puttelaar, Reinier G.S. Meester, Iris Lansdorp‐Vogelaar et al.|Cancer Epidemiology Biomarkers & Prevention|2022Cited by 29
Characteristics of a cost-effective blood test for colorectal cancer screeningPedro Nascimento de Lima, Carolyn M. Rutter, Fernando Alarid‐Escudero et al.|JNCI Journal of the National Cancer Institute|2024Cited by 26
Projected long-term effects of colorectal cancer screening disruptions following the COVID-19 pandemicPedro Nascimento de Lima, Carolyn M. Rutter, Rosita van den Puttelaar et al.|eLife|2023Cited by 21
NordICC Trial Results in Line With Expected Colorectal Cancer Mortality Reduction After Colonoscopy: A Modeling StudyD Berg, Lucie de Jonge, Pedro Nascimento de Lima et al.|Gastroenterology|2023Cited by 12